Dr. Jeanette Boudreau, PhD
Assistant Professor, Department of Microbiology and Immunology
Natural Killer cells, NK immunogenetics, cancer gene and expression profiling, bioinformatics
Precision natural killer cell therapy
Cancer results when mutations in a person’s DNA drive uncontrolled growth of a population of cells. Therefore, even with many common features, cancer is a unique disease in each patient. The Boudreau laboratory is defining the features of tumours that result from genetic mutations that can be targeted by a population of white blood cells called natural killers (NK), aiming to develop NK cells as precise effectors for immunotherapy.